Filing Signals

Source: SEC EDGAR Compiled 2026-11-14 10:32 UTC 23 automated checks passing

← All events

Immuron Ltd

CIK 1660046 IMRN·Pharmaceutical Preparations · All EDGAR filings ↗

Material weakness high Filing comparison

Immuron Ltd reported a material weakness in internal control

Internal control reported effective → Material weakness in internal control

Section 404 of the Sarbanes-Oxley Act of 2002 requires annual management assessments of the effectiveness of our internal control over financial reporting. As of June 30, 2026, our management identified a material weakness in our internal control over financial reporting relating to the recording, classification, valuation and reconciliation of inventory and the associated cost of goods sold. As a result, management concluded that, as of June 30, 2026, our internal control over financial reporting and our…
Evidence
Current state
material_weakness
Current state label
Material weakness in internal control
Direction
newly reported
Prior filed
2025-09-25
Prior form
20-F
Prior state
effective
Prior state label
Internal control reported effective
Remediation stated
Yes
Severity
high
Source
Item 9A internal control conclusion, compared with the prior filing
Why
The company's conclusion on internal control over financial reporting changed: a material weakness was newly reported, or a previously reported one no longer appears.